| Year |
Citation |
Score |
| 2024 |
Fonoudi H, Jouni M, Cejas RB, Magdy T, Blancard M, Ge N, Shah DA, Lyra-Leite DM, Neupane A, Gharib M, Jiang Z, Sapkota Y, Burridge PW. Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes. Jacc. Cardiooncology. 6: 38-50. PMID 38510289 DOI: 10.1016/j.jaccao.2023.11.008 |
0.686 |
|
| 2023 |
Romero-Tejeda M, Fonoudi H, Weddle CJ, DeKeyser JM, Lenny B, Fetterman KA, Magdy T, Sapkota Y, Epting C, Burridge PW. A novel transcription factor combination for direct reprogramming to a spontaneously contracting human cardiomyocyte-like state. Journal of Molecular and Cellular Cardiology. PMID 37421991 DOI: 10.1016/j.yjmcc.2023.06.005 |
0.663 |
|
| 2023 |
Lyra-Leite DM, Copley RR, Freeman PP, Pongpamorn P, Shah D, McKenna DE, Lenny B, Pinheiro EA, Weddle CJ, Gharib M, Javed H, Fonoudi H, Sapkota Y, Burridge PW. Nutritional requirements of human induced pluripotent stem cells. Stem Cell Reports. 18: 1371-1387. PMID 37315525 DOI: 10.1016/j.stemcr.2023.05.004 |
0.766 |
|
| 2023 |
Romero-Tejeda M, Fonoudi H, Weddle CJ, DeKeyser JM, Lenny B, Fetterman KA, Magdy T, Sapkota Y, Epting C, Burridge PW. A Novel Transcription Factor Combination for Direct Reprogramming to a Spontaneously Contracting Human Cardiomyocyte-like State. Biorxiv : the Preprint Server For Biology. PMID 36993577 DOI: 10.1101/2023.03.14.532629 |
0.663 |
|
| 2021 |
Magdy T, Jouni M, Kuo HH, Weddle CJ, Lyra-Leite D, Fonoudi H, Romero-Tejeda M, Gharib M, Javed H, Fajardo G, Ross CJD, Carleton BC, Bernstein D, Burridge PW. Identification of Drug Transporter Genomic Variants and Inhibitors that Protect Against Doxorubicin-Induced Cardiotoxicity. Circulation. PMID 34874743 DOI: 10.1161/CIRCULATIONAHA.121.055801 |
0.721 |
|
| 2021 |
Magdy T, Jiang Z, Jouni M, Fonoudi H, Lyra-Leite D, Jung G, Romero-Tejeda M, Kuo HH, Fetterman KA, Gharib M, Burmeister BT, Zhao M, Sapkota Y, Ross CJ, Carleton BC, et al. RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy. Cell Stem Cell. PMID 34525346 DOI: 10.1016/j.stem.2021.08.006 |
0.717 |
|
| 2021 |
Lyra-Leite DM, Fonoudi H, Gharib M, Burridge PW. An updated protocol for the cost-effective and weekend-free culture of human induced pluripotent stem cells. Star Protocols. 2: 100213. PMID 33786455 DOI: 10.1016/j.xpro.2020.100213 |
0.752 |
|
| 2021 |
Fonoudi H, Lyra-Leite DM, Javed HA, Burridge PW. Generating a Cost-Effective, Weekend-Free Chemically Defined Human Induced Pluripotent Stem Cell (hiPSC) Culture Medium. Current Protocols in Stem Cell Biology. 53: e110. PMID 32463953 DOI: 10.1002/Cpsc.110 |
0.771 |
|
| 2020 |
Fonoudi H, Burridge PW. Cellular model systems to study cardiovascular injury from chemotherapy. Journal of Thrombosis and Thrombolysis. 51: 890-896. PMID 33051807 DOI: 10.1007/s11239-020-02299-x |
0.616 |
|
| 2020 |
Kuo HH, Gao X, DeKeyser JM, Fetterman KA, Pinheiro EA, Weddle CJ, Fonoudi H, Orman MV, Romero-Tejeda M, Jouni M, Blancard M, Magdy T, Epting CL, George AL, Burridge PW. Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture. Stem Cell Reports. PMID 31928950 DOI: 10.1016/J.Stemcr.2019.12.007 |
0.765 |
|
| 2020 |
Fonoudi H, Wilcox J, Burridge PW. Abstract 251: Modeling LMNA Associated Cardiomyopathy Using Patient-Specific Human Induced Pluripotent Stem Cells Circulation Research. 127. DOI: 10.1161/res.127.suppl_1.251 |
0.632 |
|
| 2018 |
Ghazizadeh Z, Fattahi F, Mirzaei M, Bayersaikhan D, Lee J, Chae S, Hwang D, Byun K, Tabar MS, Taleahmad S, Mirshahvaladi S, Shabani P, Fonoudi H, Haynes PA, Baharvand H, et al. Prospective Isolation of ISL1Cardiac Progenitors from Human ESCs for Myocardial Infarction Therapy. Stem Cell Reports. PMID 29503094 DOI: 10.1016/J.Stemcr.2018.01.037 |
0.43 |
|
| 2017 |
Ghazizadeh Z, Rassouli H, Fonoudi H, Alikhani M, Talkhabi M, Darbandi-Azar A, Chen S, Baharvand H, Aghdami N, Salekdeh GH. Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells. Molecular Biotechnology. PMID 28509990 DOI: 10.1007/S12033-017-0007-X |
0.451 |
|
| 2017 |
Fonoudi H, Bosman A. Turning Potential Into Action: Using Pluripotent Stem Cells to Understand Heart Development and Function in Health and Disease. Stem Cells Translational Medicine. 6: 1452-1457. PMID 28337852 DOI: 10.1002/Sctm.16-0476 |
0.422 |
|
| 2017 |
Harvey RP, Waardenberg A, Schonrock N, Bouveret R, Ramialison M, Fonoudi H. Transcriptional Targets in Heart Development and Off-Targets in Congenital Heart Disease Mechanisms of Development. 145: S14. DOI: 10.1016/J.Mod.2017.04.565 |
0.405 |
|
| 2016 |
Fonoudi H, Ansari H, Abbasalizadeh S, Blue GM, Aghdami N, Winlaw DS, Harvey RP, Bosman A, Baharvand H. Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol. Journal of Visualized Experiments : Jove. PMID 27500408 DOI: 10.3791/54276 |
0.587 |
|
| 2015 |
Fonoudi H, Ansari H, Abbasalizadeh S, Larijani MR, Kiani S, Hashemizadeh S, Zarchi AS, Bosman A, Blue GM, Pahlavan S, Perry M, Orr Y, Mayorchak Y, Vandenberg J, Talkhabi M, et al. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells. Stem Cells Translational Medicine. PMID 26511653 DOI: 10.5966/Sctm.2014-0275 |
0.583 |
|
| 2015 |
Ghazizadeh Z, Vahdat S, Fattahi F, Fonoudi H, Omrani G, Gholampour M, Aghdami N. Isolation and characterization of cardiogenic, stem-like cardiac precursors from heart samples of patients with congenital heart disease. Life Sciences. 137: 105-15. PMID 26165749 DOI: 10.1016/J.Lfs.2015.07.006 |
0.366 |
|
| 2015 |
Bouveret R, Waardenberg AJ, Schonrock N, Ramialison M, Doan T, de Jong D, Bondue A, Kaur G, Mohamed S, Fonoudi H, Chen CM, Wouters M, Bhattacharya S, Plachta N, Dunwoodie SL, et al. NKX2-5 mutations causative for congenital heart disease retain functionality and are directed to hundreds of targets. Elife. 4. PMID 26146939 DOI: 10.7554/Elife.06942 |
0.444 |
|
| 2015 |
Bouveret R, Waardenberg AJ, Schonrock N, Ramialison M, Doan T, Jong Dd, Bondue A, Kaur G, Mohamed S, Fonoudi H, Chen C, Wouters MA, Bhattacharya S, Plachta N, Dunwoodie SL, et al. Author response: NKX2-5 mutations causative for congenital heart disease retain functionality and are directed to hundreds of targets Elife. DOI: 10.7554/Elife.06942.032 |
0.409 |
|
| 2013 |
Fonoudi H, Yeganeh M, Fattahi F, Ghazizadeh Z, Rassouli H, Alikhani M, Mojarad BA, Baharvand H, Salekdeh GH, Aghdami N. ISL1 protein transduction promotes cardiomyocyte differentiation from human embryonic stem cells. Plos One. 8: e55577. PMID 23383231 DOI: 10.1371/Journal.Pone.0055577 |
0.494 |
|
| 2012 |
Moraveji SF, Attari F, Shahverdi A, Sepehri H, Farrokhi A, Hassani SN, Fonoudi H, Aghdami N, Baharvand H. Inhibition of glycogen synthase kinase-3 promotes efficient derivation of pluripotent stem cells from neonatal mouse testis. Human Reproduction (Oxford, England). 27: 2312-24. PMID 22693173 DOI: 10.1093/Humrep/Des204 |
0.476 |
|
| Show low-probability matches. |